Report cover image

Necrotizing Enterocolitis Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385882

Description

Necrotizing Enterocolitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on necrotizing enterocolitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for necrotizing enterocolitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The necrotizing enterocolitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Treatment: Total Parenteral Nutrition (TPN); Gastrointestinal Decompression; Antimicrobial Therapy; Antifungal Treatment; Paracentesis; Other Treatments

2) By Diagnosis: Laboratory Tests; Imaging Techniques

3) By Stage: Stage I (Suspected Necrotizing Enterocolitis); Stage II (Definite Necrotizing Enterocolitis); Stage III (Advanced Necrotizing Enterocolitis)

4) By Distribution Channel: Direct Tender; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) By End-User: Hospitals; Neonatal Intensive Care Units (NICUs); Specialty Clinics

Subsegments:

1) By Total Parenteral Nutrition (TPN): Standard TPN Formulations; Customized Or Individualized TPN Solutions; Lipid Emulsions for TPN; Protein And Amino Acid Supplements In TPN; Micronutrient And Electrolyte-Enhanced TPN

2) By Gastrointestinal Decompression: Nasogastric Tube (NG Tube) Decompression; Orogastric Tube Decompression; Surgical Gastrostomy for Decompression; Non-Surgical Decompression Techniques

3) By Antimicrobial Therapy: Broad-Spectrum Antibiotics; Gram-Positive Coverage Antibiotics; Gram-Negative Coverage Antibiotics; Combination Antibiotic Therapy; Prophylactic Antibiotic Strategies For High-Risk Neonates

4) By Antifungal Treatment: Systemic Antifungal Therapy; Prophylactic Antifungal Therapy For Preterm Infants; Combination Antifungal And Antibiotic Therapy For Severe NEC

5) By Paracentesis: Diagnostic Paracentesis; Therapeutic Paracentesis; Guided Paracentesis using Ultrasound Or Radiological Techniques

6) By Other Treatments: Probiotics And Prebiotics for NEC Prevention; Surgical Interventions; Stem Cell Therapy And Regenerative Medicine Approaches; Immunomodulatory Therapies; Supportive Care

Companies Mentioned: Abbott Laboratories; Astellas Pharma Inc.; Mayo Foundation for Medical Education and Research; Cleveland Clinic; Boston Children's Hospital; Hollister Incorporated; UPMC Children's Hospital of Pittsburgh; Prolacta Bioscience Inc.; Evolve BioSystems; Sigma-Tau Pharmaceuticals; Mead Johnson & Company LLC; Liminal BioSciences Inc.; Noveome Biotherapeutics Inc.; Infant Bacterial Therapeutics; Prometic Life Sciences Inc.; Nexilico; Siolta Therapeutics; ProThera Biologics Inc.; Plakous Therapeutics Inc.; Chosen Diagnostics Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Leber Congenital Amaurosis Market Characteristics
3. Leber Congenital Amaurosis Market Trends And Strategies
4. Leber Congenital Amaurosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Leber Congenital Amaurosis Growth Analysis And Strategic Analysis Framework
5.1. Global Leber Congenital Amaurosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Leber Congenital Amaurosis Market Growth Rate Analysis
5.4. Global Leber Congenital Amaurosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Leber Congenital Amaurosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Leber Congenital Amaurosis Total Addressable Market (TAM)
6. Leber Congenital Amaurosis Market Segmentation
6.1. Global Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Therapy
Pharmaceutical Drugs
Retinal Prosthesis
Assistive Devices
Other Treatments
6.2. Global Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Congenital Leber Congenital Amaurosis (LCA) (From Birth)
Early Childhood Leber Congenital Amaurosis (LCA) (1-5 Years)
Late-Onset Leber Congenital Amaurosis (LCA) (6 Years And Above)
6.3. Global Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct Tender
Retail Sales
6.4. Global Leber Congenital Amaurosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialized Eye Clinics
Ophthalmology Research Centers
Home Care Settings
Other End Users
6.5. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
RPE65 Gene Replacement Therapy
CRISPR-Based Gene Editing
AAV (Adeno-Associated Virus) Vector Therapy
Emerging Experimental Gene Therapies
6.6. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Pharmaceutical Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retinoid-Based Therapies
Neuroprotective Agents
Anti-Inflammatory Drugs
Antioxidant Therapies
6.7. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Retinal Prosthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Implantable Retinal Chips
Artificial Retinal Stimulation Devices
Bionic Eye Technology
6.8. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Assistive Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Low Vision Aids
Screen Readers and Braille Devices
Mobility Aids for Vision Impairment
6.9. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stem Cell Therapy
Optogenetics-Based Treatments
Visual Rehabilitation Programs
Nutritional and Dietary Interventions
7. Leber Congenital Amaurosis Market Regional And Country Analysis
7.1. Global Leber Congenital Amaurosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Leber Congenital Amaurosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Leber Congenital Amaurosis Market
8.1. Asia-Pacific Leber Congenital Amaurosis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Leber Congenital Amaurosis Market
9.1. China Leber Congenital Amaurosis Market Overview
9.2. China Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Leber Congenital Amaurosis Market
10.1. India Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Leber Congenital Amaurosis Market
11.1. Japan Leber Congenital Amaurosis Market Overview
11.2. Japan Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Leber Congenital Amaurosis Market
12.1. Australia Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Leber Congenital Amaurosis Market
13.1. Indonesia Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Leber Congenital Amaurosis Market
14.1. South Korea Leber Congenital Amaurosis Market Overview
14.2. South Korea Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Leber Congenital Amaurosis Market
15.1. Western Europe Leber Congenital Amaurosis Market Overview
15.2. Western Europe Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Leber Congenital Amaurosis Market
16.1. UK Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Leber Congenital Amaurosis Market
17.1. Germany Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Leber Congenital Amaurosis Market
18.1. France Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Leber Congenital Amaurosis Market
19.1. Italy Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Leber Congenital Amaurosis Market
20.1. Spain Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Leber Congenital Amaurosis Market
21.1. Eastern Europe Leber Congenital Amaurosis Market Overview
21.2. Eastern Europe Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Leber Congenital Amaurosis Market
22.1. Russia Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Leber Congenital Amaurosis Market
23.1. North America Leber Congenital Amaurosis Market Overview
23.2. North America Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Leber Congenital Amaurosis Market
24.1. USA Leber Congenital Amaurosis Market Overview
24.2. USA Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Leber Congenital Amaurosis Market
25.1. Canada Leber Congenital Amaurosis Market Overview
25.2. Canada Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Leber Congenital Amaurosis Market
26.1. South America Leber Congenital Amaurosis Market Overview
26.2. South America Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Leber Congenital Amaurosis Market
27.1. Brazil Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Leber Congenital Amaurosis Market
28.1. Middle East Leber Congenital Amaurosis Market Overview
28.2. Middle East Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Leber Congenital Amaurosis Market
29.1. Africa Leber Congenital Amaurosis Market Overview
29.2. Africa Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Leber Congenital Amaurosis Market Competitive Landscape And Company Profiles
30.1. Leber Congenital Amaurosis Market Competitive Landscape
30.2. Leber Congenital Amaurosis Market Company Profiles
30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novelion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Leber Congenital Amaurosis Market Other Major And Innovative Companies
31.1. Andelyn Biosciences Inc.
31.2. CD Genomics Inc.
31.3. Editas Medicine Inc.
31.4. MeiraGTx Holdings plc
31.5. Sangamo Therapeutics Inc.
31.6. LKC Technologies Inc.
31.7. Aldeyra Therapeutics Inc.
31.8. Asper Biogene OÜ
31.9. Allergan Inc.
31.10. ProQR Therapeutics N.V.
31.11. GenSight Biologics S.A.
31.12. Ocugen Inc.
31.13. IVERIC bio Inc. (formerly Ophthotech Corporation)
31.14. Atsena Therapeutics Inc.
31.15. HuidaGene Therapeutics Co. Ltd.
32. Global Leber Congenital Amaurosis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Leber Congenital Amaurosis Market
34. Recent Developments In The Leber Congenital Amaurosis Market
35. Leber Congenital Amaurosis Market High Potential Countries, Segments and Strategies
35.1 Leber Congenital Amaurosis Market In 2029 - Countries Offering Most New Opportunities
35.2 Leber Congenital Amaurosis Market In 2029 - Segments Offering Most New Opportunities
35.3 Leber Congenital Amaurosis Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.